We have formed a balanced team, with experience and ability to
develop an ambitious goal:
Luis Antonio Morró
Businessman. Business development manager. Chairman of the Board of Directors of TRL+. Startup Advisor.
Research engineer in computing and AI, entrepreneur. Liaison with research teams and with the university ecosystem. Expert in artificial intelligence and machine learning.
Alvaro Miguel Cabrera
Entrepreneur, investor and business angel, responsible for business development, connection with the entrepreneurial system and investors.
Computer engineer and entrepreneur. Responsible for technological mining and liaison with research teams.
Entrepreneur and business angel.
Responsible for team building and talent selection.
“We build bridges between research and society.“
TRL+, value proposition
- We aspire to the cogeneration of Technology-Based Companies (TBC’s) of high value in the market, society and for the economy, originating from the most advanced and disruptive research projects found in the Research Centers of the Universities, thanks to the union from the genesis of professional business teams and researchers.
- These companies must be solid from their conception and subsequent launch, in order to be attractive to all stakeholders and therefore develop to their maximum capacities with the purpose of exponentially returning to Society the value of the investment made in research.
- This formula is new in the current entrepreneurial ecosystem; To date, only the projects developed by the researchers themselves, without the support of business teams that, despite this, managed to: self-generate, survive and reach a certain maturity, could be presented to the market in front of investors or open innovation systems and thus have some scalability.
- Our proposal covers the uncertainty about how to formalize and base the business structure, saves the lack of capacity for self-generation of the company that usually exists in research groups and marks the milestones of the development plan, as well as that of its early viability.